title: Strategic imperatives for globalization of industries in developing countries: an Indian pharmaceutical industry example.
abstract: The annual global pharmaceutical sales have grown over 466 billion dollars, almost 50% of which comes from North America. Among developing countries, India, with 16% of the world population, accounts for only a small percentage of the global pharmaceutical industry. Until recently, India has had virtually no pharmaceutical industry worth the name producing drugs from basic raw materials and it used to rely mostly on the imports from countries like the USA and England for all its requirements of drugs. On the other hand, India has seen a plethora of multinational pharmaceutical companies come and do business in India. This paper develops a matrix which provides a broad guidance to the mid- to large-size Indian pharmaceutical domestic companies, which should embark on the path to global expansion to establish their might as well.
authors.affiliation: Marketing and Legal Studies, University of Louisiana at Lafayette, Lafayette, LA, USA.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Srivastava
authors.forename: Ashish
authors.initials: A
authors.lastname: Chandra
authors.forename: Girish
authors.initials: G
authors.lastname: Kumar
mesh_terms: D003906:Developing Countries; D004345:Drug Industry / Q000458:organization & administration*; D007194:India; D038622:Internationality; D040541:Marketing / Q000458:organization & administration*